Literature DB >> 20954973

Pulmonary hypertension in hemodialysis patients without arteriovenous fistula: the effect of dialyzer composition.

Ahmet Alper Kiykim1, Mehmet Horoz, Turkay Ozcan, Ibrahim Yildiz, Sibel Sari, Gultekin Genctoy.   

Abstract

Pulmonary hypertension (PHT) increases mortality rate in hemodialysis (HD) patients. Numerous clinical, hemodynamic, and metabolic abnormalities have been suggested to be associated with the development of PHT in HD patients. We aimed to investigate the acute effects of two different dialyzer membranes on pulmonary arterial pressure (PAP) throughout a HD session in maintenance HD patients. Seventy-four HD patients dialyzed through permanent tunneled jugular central venous catheter were enrolled. A first-use cellulose acetate and high-flux polysulfone dialysis membrane were tested using a crossover design. For each membrane, pre- and post-dialysis pulmonary artery pressures were measured echocardiographically. Elevated pulmonary artery pressure was observed in 68.8% of patients (n = 51), whereas mild PHT was observed in 28.3% of patients (n = 21) and moderate PHT in 40.5% (n = 30). Decrease in pulmonary artery pressure following HD procedure performed using high-flux polysulfone membrane was significantly higher than the decrease observed following HD procedure performed using cellulose acetate membrane (p < 0.05). Significant decrease in pulmonary artery pressures was observed only after HD procedures performed using high-flux polysulfone membrane (p < 0.05). Ultrafiltered volume was only significantly correlated with the decrease in pulmonary artery pressure observed after HD procedure performed through high-flux polysulfone membrane (β = 0.411, p < 0.05). PHT seems to be prevalent among HD patients even in the absence of AV fistula and abnormal cardiac functions. Membrane composition seems to be important, which may overwhelm the improving effects of ultrafiltration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20954973     DOI: 10.3109/0886022X.2010.516854

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  7 in total

1.  Risk factors for pulmonary hypertension in maintenance hemodialysis patients: a cross-sectional study.

Authors:  Yanjun He; Yuling Wang; Xingying Luo; Jianting Ke; Yi Du; Mi Li
Journal:  Int Urol Nephrol       Date:  2015-11       Impact factor: 2.370

2.  Pulmonary Hypertension and Right Heart Failure in Chronic Kidney Disease: New Challenge for 21st-Century Cardionephrologists.

Authors:  L Di Lullo; F Floccari; R Rivera; V Barbera; A Granata; G Otranto; A Mudoni; M Malaguti; A Santoboni; C Ronco
Journal:  Cardiorenal Med       Date:  2013-07       Impact factor: 2.041

3.  Prevalence of pulmonary hypertension in patients with chronic kidney disease without dialysis: a meta-analysis.

Authors:  Weifeng Shang; Yuanyuan Li; Yali Ren; Wei Li; HongLan Wei; Junwu Dong
Journal:  Int Urol Nephrol       Date:  2018-03-26       Impact factor: 2.370

4.  The Relationship of Fluid Overload as Assessed by Bioelectrical Impedance Analysis with Pulmonary Arterial Hypertension in Hemodialysis Patients.

Authors:  Süreyya Yılmaz; Yasar Yildirim; Mahsuk Taylan; Melike Demir; Zülfükar Yilmaz; Ali Veysel Kara; Fatma Aydin; Hadice Selimoglu Sen; Aziz Karabulut; Fusun Topcu
Journal:  Med Sci Monit       Date:  2016-02-14

5.  Pulmonary hypertension: prevalence and risk factors.

Authors:  Samia Ait Faqih; Béfa Noto-Kadou-Kaza; Lalla Meryam Abouamrane; Naoufal Mtiou; Selma El Khayat; Mohamed Zamd; Ghislaine Medkouri; Mohamed Gharbi Benghanem; Benyounes Ramdani
Journal:  Int J Cardiol Heart Vasc       Date:  2016-05-09

Review 6.  Epidemiology, Pathogenesis, and Clinical Approach in Group 5 Pulmonary Hypertension.

Authors:  Mazen Al-Qadi; Barbara LeVarge; H James Ford
Journal:  Front Med (Lausanne)       Date:  2021-03-25

7.  A porcine model of hemodialyzer reactions: roles of complement activation and rinsing back of extracorporeal blood.

Authors:  Ákos Pethő; Dorothea Piecha; Tamás Mészáros; Rudolf Urbanics; Christoph Moore; Bernard Canaud; László Rosivall; Tom Eirik Mollnes; Sonja Steppan; Gábor Szénási; János Szebeni; László Dézsi
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.